Emergence of Candida albicans fungemia during voriconazole therapy

Journal of Infection

Volumn 51, Issue 3, 2005, Pages

  Mohammedi, Ismael ^a   Thiebaut, A ^a   Piens, M A ^b   Argaud, L ^a   Martin, O ^a   Robert, D ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPOFUNGIN; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; DOBUTAMINE; FLUCONAZOLE; FUNGUS ANTIBODY; GRANULOCYTE COLONY STIMULATING FACTOR; IMIPENEM; METHOTREXATE; NORADRENALIN; OFLOXACIN; TEICOPLANIN; THYMOCYTE ANTIBODY; VORICONAZOLE;

ABDOMINAL RADIOGRAPHY; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBIOTIC THERAPY; ANTIBODY DETECTION; APLASTIC ANEMIA; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDIASIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEATH; FEMALE; FEVER; FUNGEMIA; GRAFT VERSUS HOST REACTION; HUMAN; HYPOTENSION; LIVER FUNCTION TEST; LIVER INJURY; MENTAL DISEASE; MINIMUM INHIBITORY CONCENTRATION; MULTIPLE ORGAN FAILURE; MYCOSIS; NONHUMAN; OLIGURIA; RESPIRATORY FAILURE; SEPSIS; SPLEEN INJURY; TACHYCARDIA;

ADULT; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; FATAL OUTCOME; FEMALE; FUNGEMIA; HUMANS; MICROBIAL SENSITIVITY TESTS; PYRIMIDINES; TRIAZOLES;

EID: 27644437248     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2004.08.032     Document Type: Article

References (11)

1. J.H. Rex J.E. Bennett A.M. Sugar et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia N Engl J Med 331 1994 1325-30
2. A. Bohme M. Ruhnke D. Buchheidt et al. Treatment of fungal infections in hematology and oncology. Guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Oncology Ann Hematol 82 2003 S133-S140
3. A. Sanguineti J.K. Carmichael K. Campbell Fluconazole-resistant Candida albicans after long-term suppressive therapy Arch Intern Med 153 1993 1122-4
4. E.M. Johnson D.W. Warnock J. Luker S.R. Porter C. Scully Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis J Antimicrob Chemother 35 1995 103-14
5. M.A. Pfaller D.J. Diekema S.A. Messer L. Boyken R.J. Hollis Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: Report from the ARTEMIS Global Antifungal Susceptibility Program, 2001 J Clin Microbiol 41 2003 1440-6
6. R. Ally D. Schurmann W. Kreisel et al. A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients Clin Infect Dis 33 2001 1447-54
7. M. Cuenca-Estrella T.M. Diaz-Guerra E. Mellado A. Monzon J.L. Rodriguez-Tudela Comparative in vitro activity of voriconazole and itraconazole against fluconazole-susceptible and fluconazole-resistant clinical isolates of Candida species from Spain Eur J Clin Microbiol Infect Dis 18 1999 432-5
8. M.A. Pfaller S.A. Messer R.J. Hollis R.N. Jones D.J. Diekema In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp Antimicrob Agents Chemother 46 2002 1723-7
9. J.A. Sangeorzan S.F. Bradley X. He L.T. Zarins G.L. Ridenour R.N. Tiballi C.A. Kauffman Epidemiology of oral candidiasis in HIV-infected patients: Colonization, infection, treatment, and emergence of fluconazole resistance Am J Med 97 1994 339-46
10. K.A. Marr T.C. White J.A. van Burik R.A. Bowden Development of fluconazole resistance in Candida albicans causing disseminated infection in a patient undergoing marrow transplantation Clin Infect Dis 25 1997 908-10
11. M.E. Klepser D. Malone R.E. Lewis E.J. Ernst M.A. Pfaller Evaluation of voriconazole pharmacodynamics using time-kill methodology Antimicrob Agents Chemother 44 2000 1917-20